---
category: news
title: "BioXcel Therapeutics to Present BXCL701 Clinical Data at the Society for Immunotherapy of ..."
excerpt: "Encouraging signals of activity in difficult-to-treat tumors observed in both ongoing trials with BXCL701 and pembrolizumab (KEYTRUDA®) NEW HAVEN, Conn., Nov. 09, 2020 (GLOBE NEWSWIRE) -- BioXcel Therapeutics,"
publishedDateTime: 2020-11-09T13:07:00Z
originalUrl: "https://apnews.com/press-release/globenewswire-mobile/business-corporate-news-drug-trials-products-and-services-cancer-b095999fba8a129d71570a0d9e1b2838"
webUrl: "https://apnews.com/press-release/globenewswire-mobile/business-corporate-news-drug-trials-products-and-services-cancer-b095999fba8a129d71570a0d9e1b2838"
type: article
quality: 28
heat: -1
published: false

provider:
  name: Associated Press
  domain: apnews.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://apnews.com/images/PaidContent3.png"
    width: 700
    height: 450
    isCached: true

related:
  - title: "BioXcel Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update"
    excerpt: "Complete NDA submission for BXCL501 for the acute treatment of agitation in patients with schizophrenia and bipolar disorders on track for Q1"
    publishedDateTime: 2020-11-12T12:13:00Z
    webUrl: "https://markets.businessinsider.com/news/stocks/bioxcel-therapeutics-reports-third-quarter-2020-financial-results-and-provides-business-update-1029795792"
    ampWebUrl: "https://markets.businessinsider.com/amp/news/BioXcel-Therapeutics-Reports-Third-Quarter-2020-Financial-Results-and-Provides-Business-Update-1029795792"
    cdnAmpWebUrl: "https://markets-businessinsider-com.cdn.ampproject.org/c/s/markets.businessinsider.com/amp/news/BioXcel-Therapeutics-Reports-Third-Quarter-2020-Financial-Results-and-Provides-Business-Update-1029795792"
    type: article
    provider:
      name: Business Insider
      domain: businessinsider.com
    quality: 42

secured: "N5BNMLxxu7a3RbqZE/L5QTU+GSP8arV07pZDyVADvFpZkii3TK6tJn1vxjq9Jfhs9v3w0k36+pM2Y8xu1IMge/CQJvzU/13bk1oytvRzMeSqA+XEfXciue1AMqNaagQtZ+U3FGlOkPPfEIgR2gp+/ImfbQCARFSZqqXn4homHhmT8/ffSLrfvuhE2q/K2tFA+nmNmjRrkIGGXoIagfBC7+f9y0nbA6+jlVZ2VCPW8cMh5TXmwAiqVQgyaF0U2O/wu9NC6kQwD/ARNU3KxBqBTpN5/eWvZ1J8SzfoB9EmdEv7mF7TsmyDOOXeygdzDWQegO1ZlK2o6PxRSTrw5gKQ+JAbzB76RaJvtcUJLVKKnrc=;NF+b5ect2yIzC4hcialbjA=="
---

